For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.

Rebecca Banks, from Lancashire, had tried Saxenda jabs, Weight Watchers and fasting, but nothing seemed to work.

A mother who had tried "every diet under the sun" managed to shed an impressive 11 stone using a Mounjaro weight loss jab, ...

Pfizer has terminated the development of its oral obesity candidate danuglipron after a patient on a clinical trial with the ...

A mum who tried "every diet under the sun" lost 11 stone using a Mounjaro weight loss jab - after deciding she "wanted to be ...

Pfizer was also developing a twice-daily formulation of the drug, which showed promising weight loss, but was plagued by ...

The annual meeting of the American College of Physicians (Internal Medicine Meeting) was held from April 3 to 5 in New ...

Pfizer abandoned the development of danuglipron and plans to focus its efforts on GIPR candidates and other earlier obesity programs.